Valuation
- Market cap
- 1,856,000
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 8,700
- Avg volume
- 15,676
- Day's range
- $0.04 – $0.05
- Shares out
- 38,663,000
- Stochastic %K
- 61%
- Beta
- -5.30
- Analysts
- Strong Buy
- Price target
- —
Company profile
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based...
Show more
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
- Industry
- Shell Companies
- Sector
- Financial Services
- Phone
- 415-869-1036
- Website
- https://www.oncology-pharma.com
- Address
- 1 Sansome Street, Suite 3500, San Francisco, United States
Latest news
No headlines yet.
